Molecular Characterization of Serotype III Group B-Streptococcus Isolates Causing Neonatal Meningitis

Journal of Infectious Diseases

Volumn 188, Issue 8, 2003, Pages 1132-1137

  Bidet, Philippe ^a   Brahimi, Naima ^a   Chalas, Céline ^a   Aujard, Yannick ^b   Bingen, Edouard ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DNA FRAGMENT; PROTEIN SMAI; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CPSA GENE; DISEASE ASSOCIATION; DNA DETERMINATION; DOWNSTREAM PROCESSING; GENE; GENE INSERTION; GENE PROBE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYLB GENE; MENINGITIS; MOLECULAR DYNAMICS; NEUA GENE; NEWBORN; NEWBORN DISEASE; NEWBORN MENINGITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCPB GENE; SOUTHERN BLOTTING; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS AGALACTIAE;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BLOTTING, SOUTHERN; CEREBROSPINAL FLUID; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INFANT, NEWBORN; MENINGITIS, BACTERIAL; POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 0242364655     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378517     Document Type: Article

References (19)

1. McCracken GH Jr. Group B streptococci: the new challenge in neonatal infections. J Pediatr 1973; 82:703-6.
2. Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin Infect Dis 2001; 33:751-6.
3. Bingen E, Denamur E, Lambert-Zechovsky N, et al. Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection. J Infect Dis 1992; 165:569-73.
4. Nizet V, Ferrieri P, Rubens C. Molecular pathogenesis of group B streptococcal disease in newborns. In: Stevens DL, Kaplan EL, eds. Streptococcal infections, clinical aspects, microbiology and molecular pathogenesis. New York: Oxford University Press, 2000:180-221.
5. Kogan G, Uhrin D, Brisson JR, et al. Structural and immunochemical characterization of the type VIII group B streptococcus capsular polysaccharide. J Biol Chem 1996; 271:8786-90.
6. Andrews JI, Diekema DJ, Hunter SK, et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 2000; 183:859-62.
7. Davies HD, Raj S, Adair C, Robinson J, McGeer A. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J 2001; 20:879-84.
8. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 1998; 177:998-1002.
9. Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000; 21:473-83.
10. Granlund M, Michel F, Norgren M. Mutually exclusive distribution of IS1548 and GBSi1, an active group II intron identified in human isolates of group B streptococci. J Bacteriol 2001; 183:2560-9.
11. Glaser P, Rusniok C, Buchrieser C, et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 2002; 45:1499-513.
12. Gordillo ME, Singh KV, Baker CJ, Murray BE. Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J Clin Microbiol 1993; 31:1430-4.
13. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA 1989; 86:4731-5.
14. Takahashi S, Adderson EE, Nagano Y, Nagano N, Briesacher MR, Bohnsack JF. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J Infect Dis 1998; 177:1116-9.
15. Bohnsack JF, Takahashi S, Detrick SR, et al. Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3. J Infect Dis 2001; 183:1694-7.
16. Rolland K, Marois C, Siquier V, Cattier B, Quentin R. Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis. J Clin Microbiol 1999; 37:1892-8.
17. Granlund M, Öberg L, Sellin M, Norgren M. Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. J Infect Dis 1998; 177:967-76.
18. Hauge M, Jespersgaard C, Poulsen K, Kilian M. Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect Immun 1996; 64:919-25.
19. Bohnsack JF, Whiting AA, Bradford RD, Van Frank BK, Takahashi S, Adderson EE. Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes. Infect Immun 2002; 70:134-9.